SynthesisEndocrinology, diabetes & metabolism2026
The Effect of Aronia melanocarpa (Chokeberry) on Body Weight and Fasting Blood Sugar: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Synthesis in Endocrinology, diabetes & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Effect of Aronia melanocarpa (Chokeberry) on Body Weight and Fasting Blood Sugar: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.Endocrinology, diabetes & metabolism · 2026Pooled it
- Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlant derivatives, particularly anthocyanin-rich phytochemicals, have been shown to positively influence metabolic parameters. This study aimed to systematically review and meta-analysis the effects of Aronia melanocarpa consumption on body weight and fasting blood sugar (FBS) levels.
methodsA systematic search was conducted in PubMed/Medline, Scopus, ISI Web of Science, Embase, Cochrane Library, and Google Scholar up to January 2025. Results were reported as weighted mean differences (WMDs) with 95% confidence intervals (CIs) using a random effects model. Heterogeneity among studies was evaluated with the Cochrane Q test and I-squared (I
resultsSeven studies were identified and included in this meta-analysis. The findings revealed no significant reductions in FBS (WMDs: 0.05 mmol/L, 95% CI: -0.05 to 0.16, p = 0.341), body weight (BW) (WMDs: -0.66 kg, 95% CI: -2.54, 1.22, p = 0.494), body mass index (BMI) (WMDs: 0.18 kg/m
conclusionThe present meta-analysis indicates that Aronia berry consumption does not affect the aforementioned variables. However, further clinical data and research into the mechanisms of Aronia melanocarpa are needed to better understand its potential benefits on glycemic markers and anthropometric measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.